Xueming Wu Department of Biomedical Engineering Case Western Reserve University Biography Publications Institution JoVE Articles Xueming Wu has not added a biography. If you are Xueming Wu and would like to personalize this page please email our Author Liaison for assistance. Publications Isolation, Identification and Pharmacokinetic Analysis of Fructosyl Puerarins from Enzymatic Glycosylation Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Sep, 2013 | Pubmed ID: 23948238 Peptide Targeted Tripod Macrocyclic Gd(III) Chelates for Cancer Molecular MRI Biomaterials. Oct, 2013 | Pubmed ID: 23863450 Synthesis and Evaluation of a Polydisulfide with Gd-DOTA Monoamide Side Chains As a Biodegradable Macromolecular Contrast Agent for MR Blood Pool Imaging Contrast Media & Molecular Imaging. May-Jun, 2013 | Pubmed ID: 23606425 An Efficient Novel Glycosylation of Flavonoid by β-fructosidase Resistant to Hydrophilic Organic Solvents Bioresource Technology. Feb, 2013 | Pubmed ID: 23298773 Synthesis and Evaluation of a Peptide Targeted Small Molecular Gd-DOTA Monoamide Conjugate for MR Molecular Imaging of Prostate Cancer Bioconjugate Chemistry. Aug, 2012 | Pubmed ID: 22812444 MR Molecular Imaging of Prostate Cancer with a Peptide-targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model Pharmaceutical Research. Apr, 2012 | Pubmed ID: 22139536 Polydisulfide Manganese(II) Complexes As Non-gadolinium Biodegradable Macromolecular MRI Contrast Agents Journal of Magnetic Resonance Imaging : JMRI. Mar, 2012 | Pubmed ID: 22031457 Ocular Pharmacokinetic Study Using Tâ‚ Mapping and Gd-chelate- Labeled Polymers Pharmaceutical Research. Dec, 2011 | Pubmed ID: 21691891 Synthesis and Evaluation of Nanoglobular Macrocyclic Mn(II) Chelate Conjugates As Non-gadolinium(III) MRI Contrast Agents Bioconjugate Chemistry. May, 2011 | Pubmed ID: 21473650 Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents Israel Journal of Chemistry. Aug, 2010 | Pubmed ID: 21331318 An Effective Targeted Nanoglobular Manganese(II) Chelate Conjugate for Magnetic Resonance Molecular Imaging of Tumor Extracellular Matrix Molecular Pharmaceutics. Aug, 2010 | Pubmed ID: 20481565 Stability and Biodistribution of a Biodegradable Macromolecular MRI Contrast Agent Gd-DTPA Cystamine Copolymers (GDCC) in Rats Pharmaceutical Research. Jul, 2010 | Pubmed ID: 20393871 Peptide-targeted Nanoglobular Gd-DOTA Monoamide Conjugates for Magnetic Resonance Cancer Molecular Imaging Biomacromolecules. Mar, 2010 | Pubmed ID: 20131758 Noninvasive Evaluation of Antiangiogenic Effect in a Mouse Tumor Model by DCE-MRI with Gd-DTPA Cystamine Copolymers Molecular Pharmaceutics. Feb, 2010 | Pubmed ID: 19958031 Tumor Characterization with Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice Pharmaceutical Research. Sep, 2009 | Pubmed ID: 19597972 Targeted Systemic Delivery of a Therapeutic SiRNA with a Multifunctional Carrier Controls Tumor Proliferation in Mice Molecular Pharmaceutics. May-Jun, 2009 | Pubmed ID: 19296675 A Peptide Targeted Contrast Agent Specific to Fibrin-fibronectin Complexes for Cancer Molecular Imaging with MRI Bioconjugate Chemistry. Dec, 2008 | Pubmed ID: 19053180 The Effect of Citric Acid Added to Hydroxypropyl Methylcellulose (HPMC) Matrix Tablets on the Release Profile of Vinpocetine Drug Development and Industrial Pharmacy. Jul, 2004 | Pubmed ID: 15285336 MR молекулярной визуализации рака простаты с небольшой молекулярной CLT1 пептида целевых Агента Contrast Xueming Wu1, Daniel Lindner2, Guan-Ping Yu1, Susann Brady-Kalnay3, Zheng-Rong Lu1 1Department of Biomedical Engineering, Case Western Reserve University, 2Department of Translational Hematology & Oncology Research, Cleveland Clinic, Case Western Reserve University, 3Department of Molecular Biology & Microbiology, Case Western Reserve University JoVE 50565 Medicine
MR молекулярной визуализации рака простаты с небольшой молекулярной CLT1 пептида целевых Агента Contrast Xueming Wu1, Daniel Lindner2, Guan-Ping Yu1, Susann Brady-Kalnay3, Zheng-Rong Lu1 1Department of Biomedical Engineering, Case Western Reserve University, 2Department of Translational Hematology & Oncology Research, Cleveland Clinic, Case Western Reserve University, 3Department of Molecular Biology & Microbiology, Case Western Reserve University JoVE 50565 Medicine
